dr. weber on fda approval of pembrolizumab for stage iii melanoma
Published 5 years ago • 148 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
0:59
dr. weber on the fda approval for fixed-dose of nivolumab
-
1:11
dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
0:18
copy of dr. weber on the fda approval of adjuvant dabrafenib/trametinib in braf-mutant melanoma
-
2:06
dr. weber on next steps with pembrolizumab as melanoma treatment
-
1:49
dr. luke on the fda approval of adjuvant nivolumab in melanoma
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
1:34
fda approves frontline nivolumab for advanced melanoma
-
0:49
dr. weber on emerging therapies in melanoma
-
7:34
adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib
-
1:17
dr. weber on checkmate-238 compared to other trials in melanoma
-
2:35
results of pembrolizumab in high-risk stage iii melanoma
-
1:13
clinical trials investigating the treatment of melanoma
-
1:14
dr. weber discusses advancements in melanoma
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc